CDK4 and breast carcinoma: Nevertheless, amplification of CDK4 and cyclin D1 have been reported in upwards of 15–25 % of breast cancers, while overexpression of cyclin D1 has been reported to occur in over half of all breast cancers in some published studies [44, 45, 50, 51].